Ravindra K Rawal

Years Active: 2020-2024
Publications (10 Years): 6

Maharishi Markandeshwar (Deemed to be University)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Maharishi Markandeshwar (Deemed to be University) Mar 28 2018

India

Professor :: Chemistry

Indo Soviet Friendship College of Pharmacy Nov 07 2012 - Mar 26 2018

India

Professor & Head :: Pharmaceutical Chemistry & Analysis

University of Georgia Feb 02 2009 - Oct 31 2012

United States

Postdoctoral Associate :: PBS, College of Pharmacy

Beckman Research Institute, City of Hope Jan 27 2007 - Jan 16 2009

United States

Postdoctoral Research Fellow :: Translational Vaccine Research

Publications

Swati Pawar, Ram Karan, Srija Hazarika, Mohan Lal, Ravindra K Rawal, Praveen Kumar Gupta
Synthesis, Antimicrobial Evaluation, and In Silico Studies of 2-Substituted-Phenyl-3-(5-Aryl/Heteroaryl Substituted Thiazol-2-yl) Thiazolidin-4-One Derivatives. Assay and drug development technologies (2024)
Rakesh Sahu, Sourav Goswami, G Narahari Sastry, Ravindra K Rawal
The Preventive and Therapeutic Potential of the Flavonoids in Liver Cirrhosis: Current and Future Perspectives. Chemistry & biodiversity 20 (2) (2023)
Rakesh Sahu, Sourav Goswami, G Narahari Sastry, Ravindra K Rawal
The Preventive and Therapeutic Potential of the Flavonoids in Liver Cirrhosis: Current and Future Perspectives. Chemistry & biodiversity (2023)
Rakesh Sahu, Sourav Goswami, G Narahari Sastry, Ravindra K Rawal
The Preventive and Therapeutic Potential of the Flavonoids in Liver Cirrhosis: Current and Future Perspectives. Chemistry & biodiversity 20 (2) (2023)
Rakesh Sahu, Sourav Goswami, G Narahari Sastry, Ravindra K Rawal
The Preventive and Therapeutic Potential of the Flavonoids in Liver Cirrhosis: Current and Future Perspectives. Chemistry & biodiversity 20 (2) (2023)
Shelly Pathania, Ravindra K Rawal
An update on chemical classes targeting ERK1/2 for the management of cancer. Future medicinal chemistry 12 (7) (2020)

Ravindra K Rawal.css-eqlu8i{font-size:small;padding-left:4px;}